Free Trial
NASDAQ:NTHI

Neonc Technologies Q3 2026 Earnings Results & Report

Neonc Technologies logo
$4.24 +0.50 (+13.24%)
As of 02:16 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Neonc Technologies missed analyst earnings expectations in its Q3 2026 results, released November 5, 2026. The company reported EPS of -$0.28 versus the -$0.2480 consensus estimate.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Neonc Technologies EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.2480
Beat/Miss
Missed by -$0.0320
One Year Ago EPS
N/A

Neonc Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Neonc Technologies' Q4 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules

Neonc Technologies Q3 2026 Earnings FAQ

Neonc Technologies (NASDAQ:NTHI) reported earnings of -$0.28 per share for Q3 2026, missing the consensus estimate of -$0.2480. The report was announced on Thursday, November 5, 2026.

Neonc Technologies' next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Neonc Technologies on the company's earnings history page.

Neonc Technologies Earnings Headlines

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Neonc Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neonc Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neonc Technologies and other key companies, straight to your email.

About Neonc Technologies

Neonc Technologies (NASDAQ:NTHI) is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments.

The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.

NeOnc’s work centers on advancing these drug candidates and delivery approaches; the company’s public materials describe its focus on neuro-oncology rather than a broad commercial product portfolio.

View Neonc Technologies Profile